Delivery Order SPE2DR25D3401-SPE2DR26FL1BM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,732.94 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 20, 2026, with an ultimate completion date of January 21, 2026. This firm fixed-price, non-set-aside contract was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,346.46 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price, non-set-aside contract was performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,937.78 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 20, 2026, with an ultimate completion date of January 21, 2026. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $121,701.21 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 12, 2026, with completion scheduled for January 13, 2026. This firm fixed-price, competitively awarded contract—which includes no set-aside designation—will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency awarded a delivery order valued at $15,594.53 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on January 20, 2026, with a completion date of January 21, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,954.12 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on January 20, 2026, with an ultimate completion date of January 21, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $27,013.23 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 20, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,743.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 14, 2026, with completion scheduled for January 15, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $39,335.88 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $30,717.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (quantity 90) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL1BMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,570.76 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 15, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price, non-set-aside contract will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a broad range of pharmaceutical products and medical commodities to military and veteran healthcare systems through the DLA Medical Supply Chain. Jardiance, a brand-name diabetes medication, represents one of many therapeutic products the contractor delivers under its master contract vehicle. The parent company Cencora, Inc. competes on a full and open basis for federal pharmaceutical contracts and maintains the capacity to efficiently fulfill essential medical supply requirements across multiple therapeutic domains for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 1/14/26 |